✦ LIBER ✦

Cost Analysis From Two Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in High-Risk Patients With Coronary Artery Disease

✍ Scribed by Shpend Elezi; Alban Dibra; Ulrike Folkerts; Julinda Mehilli; Sylvia Heigl; Albert Schömig; Adnan Kastrati

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sirolimus-Eluting Stents vs Paclitaxel-E

✍ A. Kastrati; A. Dibra; S. Eberle 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 35 KB

A Meta-Analysis of 16 Randomized Trials

✍ Albert Schömig; Alban Dibra; Stephan Windecker; Julinda Mehilli; José Suárez de 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 173 KB

TCT-377: Sirolimus-Eluting Stents Versus

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 248 KB

A meta-analysis of specifically designed

✍ Sebastian Kufner; Antoinette de Waha; Fabrizio Tomai; Seong-Wook Park; Seung-Wha 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Sirolimus-Eluting Stents Versus Paclitax

✍ Pramod K. Kuchulakanti; William W. Chu; Rebecca Torguson; Leonardo Clavijo; Rosw 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Sirolimus- versus paclitaxel-eluting ste

✍ Raffaele Piccolo; Salvatore Cassese; Gennaro Galasso; Roberta De Rosa; Carolina 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 438 KB